• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, September 27, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Barrow identifies new genes responsible for ALS using IMB Watson Health

Bioengineer by Bioengineer
December 14, 2016
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Barrow Neurological Institute

Barrow Neurological Institute and IBM Watson Health today announced results of a revolutionary study that has identified new genes linked to Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. The discovery gives ALS researchers new insights that will pave the way for the development of new drug targets and therapies to combat one of the world's most devastating and deadly diseases.

The groundbreaking discovery involved IBM Watson, a cutting-edge form of artificial intelligence, to help unravel the mysteries of the brain and provide Barrow scientists with never-before-known data. IBM Watson became known around the nation in 2011 when it competed against human contestants on Jeopardy, and won.

"We are very excited about this discovery," says Robert Bowser, PhD, director of the Gregory W. Fulton ALS Research Center at Barrow Neurological Institute and one of the nation's leading ALS researchers. "ALS is one of the most complicated diseases to unravel and there is no cure. We hope that the use of IBM Watson for Drug Discovery will allow us to identify new and more effective treatments for ALS. "

ALS is a progressive and degenerative disease in which the cells that control voluntary muscle movements die, leading to paralysis and, ultimately death. Scientists don't yet know what causes ALS and there is just one FDA-approved medication but is only marginally effective. Most individuals die from ALS within three to five years from the onset of symptoms. Approximately 6,000 people are diagnosed with ALS every year.

Barrow began working with IBM last year to explore unidentified genes and proteins that may be linked to ALS using its life sciences solution, Watson for Drug Discovery. The cognitive tool, which uses machine learning, natural language processing, and other cognitive reasoning technologies, was trained about proteins that Barrow already knew were related to the disease using data given by Barrow as well as all published research information surrounding ALS.

Within months, Watson for Drug Discovery rank ordered all of the nearly 1,500 genes within the human genome and proposed predictions regarding which genes might be associated with ALS. The Barrow team then examined Watson's top evidence-based predictions and found eight of the top 10 ranked genes proved to be linked to the disease. More significantly, the study found five never before linked genes associated with ALS. Without IBM Watson for Drug Discovery, researchers predict the discovery would have taken years rather than only a few months. Barrow, located at Dignity Health St. Joseph's Hospital and Medical Center and is considered one of the world's leading neuroscience centers.

"We could have individually looked at the 1,500 proteins and genes but it would have taken us much longer to do so, "says Dr. Bowser. "IBM Watson for Drug Discovery, with its robust knowledge base, was able to rapidly give us new and novel information we would not otherwise have had."

The newly launched Watson for Drug Discovery is a cloud-based offering that aims to help researchers identify new drug targets and alternative drug indications. It is among a growing portfolio of products to help the life sciences community address the long, complex and costly process of drug discovery and development. This marks IBM Watson Health's first collaboration dedicated to understanding neurological diseases.

"Traditional research tools are fast becoming inadequate to help data scientists and researchers keep pace with and find relevant insights among the now billions of documents which are spread all over the world," said Dr. Tina Moen, PharmD, Deputy Chief Health Officer for IBM Watson Health. "Watson for Drug Discovery can help organizations far more rapidly pinpoint the most promising paths to drug discovery. We are honored to support Barrow's efforts to identify the underlying cause of ALS."

###

For more information about Barrow's partnership with IBM Watson Health, please view this short video: https://youtu.be/F-qBLH6EfR8.

Media Contact

Carmelle Malkovich
[email protected]
602-406-3319

http://www.stjosephs-phx.org

############

Story Source: Materials provided by Scienmag

Share13Tweet8Share2ShareShareShare2

Related Posts

ETRI confirms possibility of wireless communication 40m underground in mine_1

ETRI confirms possibility of wireless communication 40m underground in mine

September 27, 2023
Associate Prof Rohit Ramchandra

A novel role discovered for vagus nerve

September 27, 2023

Patients who quit smoking after percutaneous coronary intervention do as well as non-smokers – unless they had smoked heavily

September 27, 2023

THE LANCET: Gender inequalities worsen women’s access to cancer prevention, detection and care; experts call for transformative feminist approach

September 27, 2023
Please login to join discussion

POPULAR NEWS

  • blank

    Microbe Computers

    59 shares
    Share 24 Tweet 15
  • A pioneering study from Politecnico di Milano sheds light on one of the still poorly understood aspects of cancer

    35 shares
    Share 14 Tweet 9
  • Fossil spines reveal deep sea’s past

    34 shares
    Share 14 Tweet 9
  • Scientists go ‘back to the future,’ create flies with ancient genes to study evolution

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ETRI confirms possibility of wireless communication 40m underground in mine

A novel role discovered for vagus nerve

Patients who quit smoking after percutaneous coronary intervention do as well as non-smokers – unless they had smoked heavily

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 56 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In